Cat allergen peptide immunotherapy reduces CD4 ⁺ T cell responses to cat allergen but does not alter suppression by CD4 ⁺ CD25 ⁺ T cells: a double‐blind placebo‐controlled study

Abstract

Allergen peptide immunotherapy alters T cell response to allergen through mechanisms other than changes in CD4(+) CD25(+) T cell suppression.